Treadmill training in sub-acute stroke

Treadmill Training for people with Sub-Acute Stroke: A phase II randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN50570295

Enrollment

100

Registered

2017-04-19

Start date

2007-05-04

Completion date

Unknown

Last updated

2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sub-acute Stroke Nervous System Diseases Sub-acute Stroke

Interventions

Participants are randomly allocated to either the intervention group or the control group. Randomisation is done after participants undergo baseline measurements using a computer generated minimisatio

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged over 18 2. Had a stroke as defined by WHO 1988 3. One minute standing balance (with or without support, this was required to allow donning a safety harness if supported treadmill training was required) 4. Medically stable 5. Within three months of stroke onset 6. Able to understand and follow verbal instructions; and 7. Able to give informed consent

Exclusion criteria

Exclusion criteria: 1. Co-existing non-stroke related neurological impairments 2. Co-morbidities precluding gait training (e.g. amputee) 3. Non-ambulant prior to stroke 4. Body weight greater than 138kg (Weight limit of equipment) 5. Unsafe to use treadmill 6. Unable to follow simple commands

Design outcomes

Primary

Measure	Time frame
Mobility is measured using the Rivermead Mobility Index at baseline, eight weeks and six months.	—

Secondary

Measure	Time frame
1. Mobility and balance is measured using the Timed Up and Go (TUG) at baseline, eight weeks and six months 2. Gait speed is measured using a 10 metre walk (10mwt), at baseline, eight weeks and six months 3. Walking endurance is measured using a six minute walk test (6minwt) at baseline, eight weeks and six months 4. Confidence in walking is measured using a vertical 10cm Visual Analogue Scale (VAS), patient interviews and following a standardised operating procedure at baseline, eight weeks and six months 5. Motor impairments and everyday motor function is measured using the Motor Assessment Scale (MAS) at baseline, eight weeks and six months 6. Dependence in Activities of Daily Living is measured using Barthel Index at baseline, eight weeks and six months 7. Self reported recovery and quality of life is measured using the Stroke Impact Scale v3.0 at baseline, eight weeks and six months	—

Measure

Time frame

1. Mobility and balance is measured using the Timed Up and Go (TUG) at baseline, eight weeks and six months 2. Gait speed is measured using a 10 metre walk (10mwt), at baseline, eight weeks and six months 3. Walking endurance is measured using a six minute walk test (6minwt) at baseline, eight weeks and six months 4. Confidence in walking is measured using a vertical 10cm Visual Analogue Scale (VAS), patient interviews and following a standardised operating procedure at baseline, eight weeks and six months 5. Motor impairments and everyday motor function is measured using the Motor Assessment Scale (MAS) at baseline, eight weeks and six months 6. Dependence in Activities of Daily Living is measured using Barthel Index at baseline, eight weeks and six months 7. Self reported recovery and quality of life is measured using the Stroke Impact Scale v3.0 at baseline, eight weeks and six months

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026